By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Atara Biotherapeutics 

2659 Townsgate Road
Suite 236
Thousand Oaks  California  91361  U.S.A.
Phone: 805-309-0888 Fax: n/a



Company News
Atara Biotherapeutics (ATRA) Announces Third Quarter 2015 Financial Results 11/6/2015 7:10:55 AM
Atara Biotherapeutics (ATRA)’s Collaborating Investigators To Present Data From Two Cellular Therapy Product Candidates At The American Society of Hematology Annual Meeting 2015 11/5/2015 8:33:56 AM
Atara Biotherapeutics (ATRA) Announces Participation In Three Investor Conferences 10/30/2015 8:42:22 AM
Atara Biotherapeutics (ATRA) And QIMR Berghofer Medical Research Institute Announce Exclusive License And Research Agreements 10/21/2015 7:33:23 AM
Atara Biotherapeutics (ATRA) Receives FDA Orphan Drug Designation For STM 434, Atara Bio's Activin Inhibitor For Ovarian Cancer 10/20/2015 7:32:17 AM
Atara Biotherapeutics (ATRA) To Host Investor Day On October 21, 2015 10/14/2015 12:57:13 PM
Atara Biotherapeutics (ATRA)’s Collaborating Investigators To Present Data At The American Society of Nephrology Kidney Week 2015 10/5/2015 7:27:54 AM
Atara Biotherapeutics (ATRA)’s PINTA 745 Improves Insulin Sensitivity And Alters Fat Metabolism In Mice Fed With A High Fat Diet 10/5/2015 7:23:01 AM
Atara Biotherapeutics (ATRA)'s T-Cell Product Candidate Activated Against Wilms' Tumor 1 Protein Demonstrates Encouraging Results In Patients With Plasma Cell Leukemia 9/24/2015 7:52:24 AM
Atara Biotherapeutics (ATRA) To Present At Upcoming Investor Conferences In September 2015 9/3/2015 10:35:17 AM